Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$246.13 - $285.47 $1.18 Million - $1.37 Million
4,784 New
4,784 $1.37 Million
Q2 2019

Aug 16, 2019

SELL
$180.24 - $205.58 $583,076 - $665,051
-3,235 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$152.46 - $198.0 $290,436 - $377,190
-1,905 Reduced 37.06%
3,235 $639,000
Q4 2018

Feb 08, 2019

SELL
$145.0 - $178.65 $14,500 - $17,865
-100 Reduced 1.91%
5,140 $806,000
Q3 2018

Nov 15, 2018

BUY
$163.25 - $177.68 $122,437 - $133,260
750 Added 16.7%
5,240 $931,000
Q2 2018

Aug 10, 2018

SELL
$155.17 - $179.78 $46,550 - $53,934
-300 Reduced 6.26%
4,490 $758,000
Q1 2018

May 03, 2018

SELL
$148.01 - $168.91 $71,044 - $81,076
-480 Reduced 9.11%
4,790 $771,000
Q4 2017

Feb 14, 2018

BUY
$143.51 - $159.74 $756,297 - $841,829
5,270
5,270 $816,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.